Literature DB >> 2056037

Prevalence of serum antibody to the type-specific glycopeptidolipid antigens of Mycobacterium avium in human immunodeficiency virus-positive and -negative individuals.

B Y Lee1, D Chatterjee, C M Bozic, P J Brennan, D L Cohn, J D Bales, S M Harrison, L A Andron, I M Orme.   

Abstract

An enzyme-linked immunosorbent assay was constructed by using as antigens the type-specific immunodominant glycopeptidolipids of selected serotypes of Mycobacterium avium. This assay system was used to determine the prevalence of raised antibody levels to these antigens in groups of controls, human immunodeficiency (HIV)-negative and -positive homosexual men, and HIV-negative patients with active M. avium infections as a possible indicator of potential exposure and/or colonization by M. avium in these individuals. The results indicate that while antibody levels were raised in only 2.4% of control individuals, 33% of HIV-negative homosexual men and 44% of HIV-positive patients exhibited raised levels. Moreover, further examination of the HIV-positive group revealed no correlation between antiglycopeptidolipid antibody activity and helper T cell numbers. These data indicate that exposure to M. avium is prevalent among the homosexual male population, regardless of their HIV status. Moreover, the data are suggestive that the emergence of disseminated M. avium disease in HIV-positive patients may sometimes arise from earlier colonization, rather than as a newly acquired infection during terminal immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2056037      PMCID: PMC269928          DOI: 10.1128/jcm.29.5.1026-1029.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

2.  Treatment of infections in patients with the acquired immunodeficiency syndrome.

Authors:  D Armstrong; J W Gold; J Dryjanski; E Whimbey; B Polsky; C Hawkins; A E Brown; E Bernard; T E Kiehn
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

3.  Structural studies on the type-specific antigens and lipids of the mycobacterium avium. Mycobacterium intracellulare. Mycobacterium scrofulaceum serocomplex. Mycobacterium intracellulare serotype 9.

Authors:  P J Brennan; M B Goren
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

4.  Mycobacterium avium-Mycobacterium intracellulare from the intestinal tracts of patients with the acquired immunodeficiency syndrome: concepts regarding acquisition and pathogenesis.

Authors:  B Damsker; E J Bottone
Journal:  J Infect Dis       Date:  1985-01       Impact factor: 5.226

Review 5.  Treatable aspects of infection due to human immunodeficiency virus.

Authors:  L S Young
Journal:  Lancet       Date:  1987-12-26       Impact factor: 79.321

6.  Identification of atypical mycobacteria by thin-layer chromatography of their surface antigens.

Authors:  P J Brennan; M Souhrada; B Ullom; J K McClatchy; M B Goren
Journal:  J Clin Microbiol       Date:  1978-10       Impact factor: 5.948

7.  The acquired immunodeficiency syndrome and Mycobacterium avium-intracellulare bacteremia in a patient with hemophilia.

Authors:  J L Elliott; W L Hoppes; M S Platt; J G Thomas; I P Patel; A Gansar
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

8.  The presence of novel glucuronic acid-containing, type-specific glycolipid antigens within Mycobacterium spp. Revision of earlier structures.

Authors:  D Chatterjee; G O Aspinall; P J Brennan
Journal:  J Biol Chem       Date:  1987-03-15       Impact factor: 5.157

9.  Mycobacterium avium-intracellulare: a cause of disseminated life-threatening infection in homosexuals and drug abusers.

Authors:  J B Greene; G S Sidhu; S Lewin; J F Levine; H Masur; M S Simberkoff; P Nicholas; R C Good; S B Zolla-Pazner; A A Pollock; M L Tapper; R S Holzman
Journal:  Ann Intern Med       Date:  1982-10       Impact factor: 25.391

10.  Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome.

Authors:  A M Macher; J A Kovacs; V Gill; G D Roberts; J Ames; C H Park; S Straus; H C Lane; J E Parrillo; A S Fauci
Journal:  Ann Intern Med       Date:  1983-12       Impact factor: 25.391

View more
  6 in total

1.  Structure of a new glycolipid from the Mycobacterium avium-Mycobacterium intracellulare complex.

Authors:  M Watanabe; A Ohta; S i Sasaki; D E Minnikin
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

2.  Mycobacterium avium infection in HIV-1-infected subjects increases monokine secretion and is associated with enhanced viral load and diminished immune response to viral antigens.

Authors:  M Denis; E Ghadirian
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

3.  Dissemination of enteric Mycobacterium avium infections in mice rendered immunodeficient by thymectomy and CD4 depletion or by prior infection with murine AIDS retroviruses.

Authors:  I M Orme; S K Furney; A D Roberts
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

Review 4.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

5.  Age-dependent humoral responses of children to mycobacterial antigens.

Authors:  M P Fairchok; J H Rouse; S L Morris
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

Review 6.  The mycobacterial glycopeptidolipids: structure, function, and their role in pathogenesis.

Authors:  Jeffrey S Schorey; Lindsay Sweet
Journal:  Glycobiology       Date:  2008-08-22       Impact factor: 4.313

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.